Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Biotechnol Bioeng ; 96(6): 1155-66, 2007 Apr 15.
Article in English | MEDLINE | ID: mdl-17058277

ABSTRACT

We describe an efficient inducible gene expression system in HEK.EBNA cells, a well-established cell system for the rapid transient expression of research-tool proteins. The transgene control system of choice is the novel acetaldehyde-inducible regulation (AIR) technology, which has been shown to modulate transgene levels following exposure of cells to acetaldehyde. For application in HEK.EBNA cells, AlcR transactivator plasmids were constructed and co-expressed with the secreted alkaline phosphatase (SEAP) gene under the control of a chimeric mammalian promoter (P(AIR)) for acetaldehyde-regulated expression. Several highly inducible transactivator cell lines were established. Adjustable transgene induction by gaseous acetaldehyde led to high induction levels and tight repression in transient expression trials and in stably transfected HEK.EBNA cell lines. Thus, the AIR technology can be used for inducible expression of any desired recombinant protein in HEK.EBNA cells. A possible application for inducible gene expression is a controlled proliferation strategy. Clonal HEK.EBNA cell lines, expressing the fungal transactivator protein AlcR, were engineered for gas-adjustable expression of the cell-cycle regulator p27(Kip1). We show that expression of p27(Kip1) via transient or stable transfection led to a G1-phase specific growth arrest of HEK.EBNA cells. Furthermore, production pools engineered for gas-adjustable expression of p27(Kip1) and constitutive expression of SEAP showed enhanced productive capacity.


Subject(s)
Alkaline Phosphatase/genetics , G1 Phase/physiology , Gene Expression Regulation , Proliferating Cell Nuclear Antigen/metabolism , Recombinant Proteins/metabolism , Acetaldehyde/metabolism , Alkaline Phosphatase/metabolism , Bioreactors , Cell Line , Epstein-Barr Virus Nuclear Antigens/metabolism , Humans , Kidney/cytology , Kidney/embryology , Recombinant Proteins/biosynthesis , Transgenes/physiology , Viral Proteins/metabolism
2.
Mol Biol Cell ; 15(3): 990-1002, 2004 Mar.
Article in English | MEDLINE | ID: mdl-14668478

ABSTRACT

Dominant keratin mutations cause epidermolysis bullosa simplex by transforming keratin (K) filaments into aggregates. As a first step toward understanding the properties of mutant keratins in vivo, we stably transfected epithelial cells with an enhanced yellow fluorescent protein-tagged K14R125C mutant. K14R125C became localized as aggregates in the cell periphery and incorporated into perinuclear keratin filaments. Unexpectedly, keratin aggregates were in dynamic equilibrium with soluble subunits at a half-life time of <15 min, whereas filaments were extremely static. Therefore, this dominant-negative mutation acts by altering cytoskeletal dynamics and solubility. Unlike previously postulated, the dominance of mutations is limited and strictly depends on the ratio of mutant to wild-type protein. In support, K14R125C-specific RNA interference experiments resulted in a rapid disintegration of aggregates and restored normal filaments. Most importantly, live cell inhibitor studies revealed that the granules are transported from the cell periphery inwards in an actin-, but not microtubule-based manner. The peripheral granule zone may define a region in which keratin precursors are incorporated into existing filaments. Collectively, our data have uncovered the transient nature of keratin aggregates in cells and offer a rationale for the treatment of epidermolysis bullosa simplex by using short interfering RNAs.


Subject(s)
Actins/metabolism , Cytoskeleton/metabolism , Epidermolysis Bullosa Simplex/metabolism , Keratinocytes/cytology , Keratins/metabolism , Biological Transport/physiology , Cells, Cultured , Epidermolysis Bullosa Simplex/etiology , Epidermolysis Bullosa Simplex/genetics , Humans , Keratinocytes/metabolism , Keratins/genetics , Mutation/genetics , RNA, Small Interfering/metabolism , Recombinant Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...